(1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ130942-96-0,Purity95%

Home>Supplier>American Peptide Company>(1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ

American Peptide Company

: Uncertified Store

: -

: United States - -

: sales@americanpeptide.com

: NULL

: 001-00000156

Hot Search

2-[[2-[[1-[2-[[4-amino-2-[[5-amino-2-[(2-amino-3-hydroxypropanoyl)amino]-5-oxopentanoyl]amino]-4-oxobutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoic acid

CAS NO.: 118071-31-1

Purity :95%

Dynorphin A (1-8), porcine;YGGFLRRI

CAS NO.: 75790-53-3

Purity :95%

Trp-Lys-Tyr-Met-Val-D-Met

CAS NO.: 187986-17-0

Purity :98%

Thrombospondin-1 (1016-1021) (human, bovine, mouse)

CAS NO.: 149234-06-0

Purity :98%

(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-oxobutanoic acid

CAS NO.: 141136-83-6

Purity :98%

Catalog No. : 89112

(1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ

CAS No : 130942-96-0
Packing : 25kg
Brand :
Purity : 95%
Loading Port :
Lead Time : 14Day (s)

Packing :

25kg

1ton

Request For Quotation

Product Details & Description

Product Info

Compound	(1-ADAMANTANEACETYL-D-ARG0,HYP3,β-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ
CAS No.	130942-96-0	Catalog No.	89112	Brand
Purity	95%	Packing	25kg	Grade
Lead Time	14Day (s)	Origin		Loading Port

PropertiesMore

Storage Condition	-20ºC

Request For Quotation

Product: (1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ

Cas No: 130942-96-0

*Purity

*Quantity

*Valid for

*Shipping To

Contact Person

*Email

*Company/Institute

Notes

I would like to have suppliers recommended by MOLBASE.

I agree to share my contact information to the supplier(s).

Other Supplier Reference

Product Name	Purity	Packing	Lead Time	Country	Store Name	Details
(1-Adamantaneacetyl-D-Arg0,Hyp3,β-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin	98%	10g	3Day (s)	China,Henan	Henan Coreychem Co.,Ltd	Request For Quotation
(1-ADAMANTANEACETYL-D-ARG0,HYP3,β-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ	98%	1mg,5mg	7Day (s)	China,Sichuan	Chengdu SinoStandards Bio-Tech Co.,Ltd.	Request For Quotation
(1-ADAMANTANEACETYL-D-ARG0,HYP3,β-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ	95%	10mg,5mg 4 spec	7Day (s)	China,Anhui	Hefei Saimanuo Biotechnology Co., Ltd.	Request For Quotation
(1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ	96%	10g,100g 3 spec	7Day (s)	United States,Idaho	American Custom Chemicals Corporation	Request For Quotation
(1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ	96%	10g,500g 3 spec	7Day (s)	Wales,	Ibookbio	Request For Quotation
(1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ	95%	25kg,1吨 3 spec	14Day (s)	Netherlands,	Brunschwig chemie	Request For Quotation
(1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ	96%	25kg,500g 3 spec	7Day (s)	Switzerland,	Bachem AG	Request For Quotation

View All Suppliers

Related Products

[Ala113]-MBP (104-118)

CAS No : 99026-78-5
[Ala107]-MBP (104-118)

CAS No : 99026-77-4
Alytesin

CAS No : 31078-12-3
MLCK inhibitor peptide

CAS No : 198694-74-5
Gap 26

CAS No : 197250-15-0
Compstatin

CAS No : 206645-99-0
α-Conotoxin AuIB

CAS No : 216299-21-7
NEUROTENSIN (1-11)

CAS No : 74032-89-6
Granuliberin R

CAS No : 64704-41-2
[D-Arg1,D-Pro2,D-Phe7,D-His9]-Substance P

CAS No : 115760-58-2
(1-ADAMANTANEACETYL-D-ARG0,HYP3,β-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ

CAS No : 130942-96-0
L-Argininamide, L-phenylalanyl-L-glutaminyl-L-tryptophyl-L-glutaminyl-L-arginyl-L-asparaginyl-L-isoleucyl-L-arginyl-L-lysyl-L-valyl-

CAS No : 832729-13-2

Chemical Product Chemical Encyclopedia Structure CAS Number Search

Compound Synonyms: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9

Home Partners Business Cooperation Suppliers About Us Contact Us Privacy Policy Terms & Conditions Disclaimer